1-2 of 2
Bjørn Tore Gjertsen, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dasatinib Treatment Induces Fast and Deep Responses In Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients In Chronic Phase: Clinical Results From a Randomized Phase 2 Study (NordCML006)

Free
Henrik Hjorth-Hansen, MD, PhD, Johan Richter, MD, PhD, Leif Stenke, MD, PhD, Hans Ehrencrona, MD, PhD, Bjørn Tore Gjertsen, MD, PhD, Tobias Gedde-Dahl, III, MD, PhD, Perttu Koskenvesa, MD, Claes Malm, MD, Waleed Majeed, MD, Lotta Ohm, MD PhD, Martin Hoglund, MD PhD, Ulla Olsson-Strömberg, MD, PhD, Stina Söderlund, MD, Merja Suominen, MD, Kari Remes, MD PhD, Berit Markevärn, MD, Bengt Simonsson, MD PhD, Kimmo Porkka, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4032.
https://doi.org/10.1182/blood.V122.21.4032.4032
Published: 2013
Journal Articles

Elacytarabine Is More Effective Preclinically Than Cytarabine In Combination With Daunorubicin In Primary Patient Xenografts Of AML

Free
Tereza Osdal, MSc, Mihaela Lucia Popa, VMD, Lene Mari Vikebø, Andre Sulen, MSc, Siv Lise Bendringaas, Marit Liland Sandvold, PhD, Birgitte Booij, PhD, Øystein Bruserud, MD, PhD, Bjørn Tore Gjertsen, MD, PhD, Emmet McCormack, PhD
Journal: Blood
Blood (2013) 122 (21): 3958.
https://doi.org/10.1182/blood.V122.21.3958.3958
Published: 2013